Abstract: In some implementations, a first device may connect to a network, wherein the first device is associated with a first application that is associated with a service provider. The first device may detect that a second device connected to the network is associated with a second application that is associated with the service provider. The first device may receive, from the second device, identification information associated with the second device. The first device may transmit, to a third device associated with the service provider, the identification information associated with the second device. The first device may receive, from the third device, authentication information permitting the first application to operate on the network based on the third device receiving the identification information associated with the second device.

Abstract: A method includes providing a programming guide including listings associated with a number of channels provided by a television service provider. The method may also include receiving, from a user, input corresponding to a request to add a listing in the programming guide associated with an online content provider, and providing a user interface requesting that the user add information associated with the online content provider. The method may further include receiving, via the user interface, an identifier associated with the online content provider, storing the identifier in a memory, and modifying the programming guide to include a listing associated with the online content provider.

Abstract: Exemplary systems and methods for preventing duplicative media content recordings are disclosed. An exemplary method includes a media content access subsystem detecting that a media content instance is scheduled to be recorded, determining, based on an operations log of one or more past operations of the media access subsystem, that the scheduled recording of the media content instance is duplicative of a past recording, and selectively canceling the scheduled recording of the media content instance in response to the determination that the scheduled recording is duplicative of the past recording. Corresponding systems and methods are also disclosed.

Abstract: A method includes providing a programming guide including listings associated with a number of channels provided by a television service provider. The method may also include receiving, from a user, input corresponding to a request to add a listing in the programming guide associated with an online content provider, and providing a user interface requesting that the user add information associated with the online content provider. The method may further include receiving, via the user interface, an identifier associated with the online content provider, storing the identifier in a memory, and modifying the programming guide to include a listing associated with the online content provider.

Abstract: Exemplary systems and methods for preventing duplicative media content recordings are disclosed. An exemplary method includes a media content access subsystem detecting that a media content instance is scheduled to be recorded, determining, based on an operations log of one or more past operations of the media access subsystem, that the scheduled recording of the media content instance is duplicative of a past recording, and selectively canceling the scheduled recording of the media content instance in response to the determination that the scheduled recording is duplicative of the past recording. Corresponding systems and methods are also disclosed.

Abstract: A method includes receiving, at a recording device, an instruction or command from a user to record television programming on a first channel for a period of time. The method also includes receiving information from the user, where the information identifies one or more names or titles to associate with the programming to be recorded on the first channel for the period of time. The method further includes recording the programming on the first channel for the period of time, receiving a request to view a list of recorded programs and outputting the list of the recorded programs, where the list includes the one or more names or titles associated with the programming on the first channel for the period of time.

Abstract: The present invention relates to anti-MAdCAM antibody compositions comprising a chelating agent, and methods of treating inflammatory disease in a subject.

Abstract: There is provided a pharmaceutical composition suitable for topical administration to an eye, the composition comprising (a) a pharmacologically effective concentration of an active agent and (b) a combination of at least two ophthalmically compatible polymers comprising a novel gum system. In preferred embodiments of the present invention, the compositions increase the retention time of the active agent in the eye, when compared to compositions with other gums or gum systems.

Abstract: A method of directly implanting embryonic or adult somatic stem cells into a desired site in a mammal, e.g., into the adult digestive tract, for gene therapy and/or cell replacement is disclosed. Stem cells with their inherent pluripotency have been found to be capable of being implanted directly, e.g., in the digestive system where they become permanently engrafted. The advantage of cultured stem cells is that they can be expanded in vitro and engineered to produce cells that stably express a variety of gene products. Stem cells directly implanted in the gastrointestinal tract according to the method of the invention, have been shown to differentiate into specialized cells of the adult gut (such as nerves, muscles and epithelia). These cells remain at the site of injection and respect local tissue architecture while permanently expressing transfected genes, e.g., nitric oxide synthase, which catalyzes the production of nitric gas in vivo.

Abstract: The present invention provides methods for the treatment and prevention of ocular COX-2 mediated disorders using COX-2 inhibitors.

Abstract: There is provided a pharmaceutical preservative free composition suitable for topical administration to an eye, the composition comprising (a) an oxazolidinone antimicrobial drug, for example linezolid, in a therapeutically or prophylactically effective drug concentration that is above the practical limit of solubility of the drug in a substantially isotonic aqueous solution at a physiologically compatible pH, and (b) a pharmaceutically acceptable cyclodextrin compound in a concentration sufficient to maintain the drug in solution at such a drug concentration. The composition is particularly useful for the treatment and/or prevention of eye infections due to gram positive bacteria.

Abstract: There is provided a pharmaceutical composition suitable for topical administration to an eye, the composition comprising (a) an antibiotic antibiotic drug, for example linezolid, in a therapeutically or prophylactically effective drug concentration, (b) as a solubilizing agent, a pharmaceutically acceptable cyclodextrin compound in a concentration sufficient to maintain the drug in solution at such a drug concentration, and (c) as a preservative, cetyl pyridinium chloride. The composition is particularly useful for the treatment and/or prevention of eye infections due to gram positive bacteria.

Abstract: There is provided a pharmaceutical composition suitable for topical administration to an eye, the composition comprising (a) a pharmacologically effective concentration of an active agent and (b) a combination of at least two ophthalmically compatible polymers comprising a novel gum system. In preferred embodiments of the present invention, the compositions increase the retention time of the active agent in the eye, when compared to compositions with other gums or gum systems.

Abstract: There is provided a pharmaceutical preservative free composition suitable for topical administration to an eye, the composition comprising (a) an oxazolidinone antimicrobial drug, for example linezolid, in a therapeutically or prophylactically effective drug concentration that is above the practical limit of solubility of the drug in a substantially isotonic aqueous solution at a physiologically compatible pH, and (b) a pharmaceutically acceptable cyclodextrin compound in a concentration sufficient to maintain the drug-in solution at such a drug concentration. The composition is particularly useful for the treatment and/or prevention of eye infections due to gram positive bacteria.

Abstract: A pharmaceutical implant for administering a biologically active substance is made up of an immediate-release component, preferably containing a disintegrating agent, and a sustained-release component. The implant of the present invention provides flexibility in adjusting the release of the medicament and a faster onset of release can be provided along with a long-term sustained-release. The release rate of the biologically active substance can be adjusted by controlling the relative quantities of the immediate-release component and the sustained-release component.

Abstract: The present invention provides methods for the treatment and prevention of ocular COX-2 mediated disorders using COX-2 inhibitors.

Abstract: There is provided a pharmaceutical composition suitable for topical administration to an eye which contains a selective COX-2 inhibitory drug or nanoparticles of a drug of low water solubility, in a concentration effective for treatment and/or prophylaxis of a disorder in the eye, and one or more ophthalmically acceptable excipients that reduce rate of removal from the eye such that the composition has an effective residence time of about 2 to about 24 hours. Also provided is a method of treating and/or preventing a disorder in an eye, the method comprising administering to the eye a composition of the invention.